检查大麻二醇对与月经有关的症状的影响
Morgan L Ferretti1, Taylor B Stanley2, Erica N Peters3
1Department of Psychological Sciences, University of Arkansas.
Experimental and clinical psychopharmacology
|March 7, 2024
概括
大麻素 (CBD) 显示在减少与月经有关的症状 (MRS),包括焦虑和压力方面具有前景. 这项研究发现,在三个月内持续每天使用CBD显著缓解了各种MRS,尽管抑郁症得分保持不变.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 妇女健康 妇女健康
- 大麻素研究 研究 大麻素研究
背景情况:
- 许多人使用大麻来管理与月经有关的症状 (MRS),但缺乏关于大麻素有效性的科学证据.
- 现有的事报告表明了潜在的益处,强调了对MRS的大麻素干预措施进行严格调查的需要.
研究的目的:
- 研究口服大麻素 (CBD) 隔离剂对缓解月经相关症状 (MRS) 的作用.
- 为了评估三个月的CBD消费后MRS,易怒,焦虑,压力和主观严重性的变化.
主要方法:
- 一项前后,随机,开放的标签试验,涉及两组每天两次 (BID) 消费160 mg或320 mg的CBD.
- 参与者每月连续五天每天服用分配的CBD剂量,持续三个月,经过一个月的基线期.
- 基线期和三个月的CBD消费结果之间进行了比较.
主要成果:
- 两组CBD剂量都显示出MRS,易怒,焦虑,总体变化印象和主观压力严重程度的显著降低.
- 从CBD消费的第一个月开始观察到症状的改善,并在整个研究中持续存在.
- 在任何服用组的抑郁症得分中都没有发现显著的变化.
结论:
- 口服大麻二醇 (CBD) 隔离物显示出作为管理月经相关症状 (MRS) 的有效干预措施的潜力.
- 在减轻包括焦虑和压力在内的症状方面观察到的好处表明CBD对妇女健康的治疗价值.
- 需要进一步的研究,包括安慰剂对照试验和优化CBD管理的探索.
更多相关视频
相关概念视频
Disorders of the Female Reproductive System
358
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
358
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
277
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
277
Drugs for Treatment of Diarrhea-Predominant IBS
169
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
169
Drugs for Treatment of Constipation-Predominant IBS
163
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
163
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome III: Medical and Nursing Management
204
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
204


